Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M107Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-4.5
Enterprise Value $M60.8EPS (TTM) $-0.4Operating Margin %--Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.6Pre-tax Margin (%)--Higher ROA y-yY
Price/Book1.510-y EBITDA Growth Rate %--Quick Ratio8.8Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-4.8Current Ratio8.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-36.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-41.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M95.0ROIC % (ttm)-133.2Gross Margin Increase y-yN

Gurus Latest Trades with ONTY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ONTYFirst Eagle Investment 2015-12-31 Buy $2.13 - $3.55
($2.87)
$ 1.13-61%New holding300,000
ONTYFirst Eagle Investment 2015-06-30 Sold Out -0.01%$1.42 - $4.09
($2.61)
$ 1.13-57%Sold Out0
ONTYFirst Eagle Investment 2015-03-31 Buy 0.01%$1.5 - $1.95
($1.63)
$ 1.13-31%New holding1,300,000
ONTYFirst Eagle Investment 2014-09-30 Sold Out -0.019%$1.92 - $3.29
($2.55)
$ 1.13-56%Sold Out0
ONTYGeorge Soros 2014-06-30 Sold Out $2.35 - $3.5
($2.94)
$ 1.13-62%Sold Out0
ONTYGeorge Soros 2014-03-31 Buy $1.71 - $3.89
($2.7)
$ 1.13-58%New holding89,600
ONTYFirst Eagle Investment 2013-09-30 Add0.01%$1.59 - $2.18
($1.75)
$ 1.13-35%Add 75.63%2,275,287
ONTYFirst Eagle Investment 2013-06-30 Add0.01%$1.57 - $2.63
($2.14)
$ 1.13-47%Add 547.75%1,295,499
ONTYFirst Eagle Investment 2013-03-31 Buy $1.86 - $2.35
($2.09)
$ 1.13-46%New holding200,000
ONTYFirst Eagle Investment 2012-03-31 Sold Out -0.0033%$4.25 - $8.96
($6.78)
$ 1.13-83%Sold Out0
ONTYFirst Eagle Investment 2011-12-31 Add$5.84 - $8.25
($6.85)
$ 1.13-84%Add 33.33%100,000
ONTYFirst Eagle Investment 2011-09-30 Reduce-0.01%$5.95 - $10.2
($7.49)
$ 1.13-85%Reduce -66.67%75,000
ONTYFirst Eagle Investment 2011-06-30 Buy 0.01%$3.8 - $9.43
($5.79)
$ 1.13-80%New holding225,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ONTY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ONTY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HAUSMAN DIANAChief Medical Officer 2015-06-01Buy5,747$4.65-75.7view
SPIEGELMAN DANIEL KDirector 2015-03-26Buy20,000$1.61-29.81view
SPIEGELMAN DANIEL KDirector 2015-03-26Buy20,000$1.61-29.81view
BVF PARTNERS L P/IL10% Owner 2014-12-17Buy378,444$1.82-37.91view
BVF PARTNERS L P/IL10% Owner 2014-12-12Sell0$0-37.91view
Venkatesan JayEVP and General Manager 2014-09-23Buy250,000$2-43.5view
BVF PARTNERS L P/IL10% Owner 2013-11-01Buy129,000$1.78-36.52view
BVF PARTNERS L P/IL10% Owner 2013-08-08Buy258,361$1.65-31.52view
BVF PARTNERS L P/IL10% Owner 2013-08-01Buy338,087$1.74-35.06view
SPIEGELMAN DANIEL KDirector 2013-07-10Sell16,183$1.91-40.84view

Quarterly/Annual Reports about ONTY:

News about ONTY:

Articles On GuruFocus.com
Value Betting with Special Situations: Lessons from the World of Gambling Mar 05 2013 
Cubist Pharmaceutical - Acutely Aware May 09 2010 

More From Other Websites
ONCOTHYREON INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... May 19 2016
ONCOTHYREON INC. Financials May 17 2016
ONCOTHYREON INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 09 2016
Oncothyreon Reports First Quarter 2016 Financial Results & Provides Corporate Update May 09 2016
Oncothyreon reports 1Q loss May 09 2016
Oncothyreon reports 1Q loss May 09 2016
Oncothyreon Reports First Quarter 2016 Financial Results & Provides Corporate Update May 09 2016
4 Biotech Stocks to Buy at Beaten Down Prices Apr 26 2016
Oncothyreon (ONTY) Catches Eye: Stock Moves 11.6% Higher Apr 26 2016
Oncothyreon Highlights Novel Checkpoint Kinase 1 Inhibitors at American Association for Cancer... Apr 19 2016
Oncothyreon Highlights Novel Checkpoint Kinase 1 Inhibitors at American Association for Cancer... Apr 19 2016
5 Stocks Under $10 Set to Soar Apr 14 2016
ONCOTHYREON INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Apr 01 2016
Seattle biotech Oncothyreon names new CEO Mar 29 2016
Oncothyreon Appoints Scott D. Myers Chief Executive Officer Mar 29 2016
ONCOTHYREON INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Mar 29 2016
Oncothyreon Appoints Scott D. Myers Chief Executive Officer Mar 29 2016
Stocks To Buy: These Are Being Considered on Monday 3/21/2016 Mar 21 2016
Three Stocks To Watch Friday Afternoon 3/18/2016 Mar 18 2016
ONCOTHYREON INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 14 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)